AllSquare Wealth Management’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1
| Closed | -$6 | – | 540 |
|
|
2025
Q1 | $6 | Hold |
1
| – | – | ﹤0.01% | 534 |
|
|
2024
Q4 | $5 | Hold |
1
| – | – | ﹤0.01% | 536 |
|
|
2024
Q3 | $39 | Hold |
1
| – | – | ﹤0.01% | 534 |
|
|
2024
Q2 | $45 | Hold |
1
| – | – | ﹤0.01% | 527 |
|
|
2024
Q1 | $72 | Hold |
1
| – | – | ﹤0.01% | 523 |
|
|
2023
Q4 | $50 | Hold |
1
| – | – | ﹤0.01% | 527 |
|
|
2023
Q3 | $48 | Hold |
1
| – | – | ﹤0.01% | 534 |
|
|
2023
Q2 | $27 | Hold |
1
| – | – | ﹤0.01% | 559 |
|
|
2023
Q1 | $26 | Hold |
1
| – | – | ﹤0.01% | 552 |
|
|
2022
Q4 | $31 | Hold |
1
| – | – | ﹤0.01% | 527 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 503 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 507 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 509 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 494 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 483 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 496 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 492 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 460 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 463 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 468 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 456 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 449 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 453 |
|
|
2019
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 458 |
|
|
2019
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 464 |
|